Phase 2 Trial: Chemotherapy Plus Immunotherapy Facilitates Bladder Sparing in Muscle-Invasive Bladder Cancer – Matthew Galsky
Ashish Kamat and Matthew Galsky discuss a phase 2 trial on organ sparing for muscle-invasive bladder cancer, published in Nature Medicine. Dr. Galsky highlights the trial’s focus on systemic therapy as an alternative to cystectomy, noting its potential for curative outcomes. The study involved patients receiving gemcitabine-cisplatin plus nivolumab, followed by clinical restaging to identify…